Wilson Troy Edwardinsider trades

In SEC Form 4 filings, Wilson Troy Edward is listed as Director of Puma Biotechnology, Inc. (PBYI) and President and CEO of Kura Oncology, Inc. (KURA). In the last 90 days, Wilson Troy Edward bought $1.24M of Kura Oncology, Inc. (KURA) and sold $45.5K of Puma Biotechnology, Inc. (PBYI) on the open market. The purchase was $1.24M of Kura Oncology, Inc. (KURA) on Aug 24. The sale was reported under a 10b5-1 trading plan.

Companies and roles

Company	Role	Transactions	Last filed
PBYIPuma Biotechnology, Inc.	Director	1	Sep 16
KURAKura Oncology, Inc.	President and CEO	1	Aug 24

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-08-24

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
PBYIPuma Biotechnology, Inc.	Sep 14	Sep 16	S	5,000	$9.10	Sale −$45,500	54,750	Yes	Form 4
KURAKura Oncology, Inc.	Aug 24	Aug 24	P	100,000	$12.39	Purchase +$1,239,000	479,194	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.